Insights from recent episode analysis
Audience Interest
Estimated Reach: 250,001+
Listeners across platforms
Podcast Focus
Categories: education · courses
+5 more
Publishing Consistency
Frequency: Irregular
200+ episodes since 2020
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
oncology
5
medical education
3
essential thrombocythemia
3
polycythemia vera
3
multidisciplinary care
2
biomarker testing
2
Brands & references
Decera Clinical Education10
Global Experts Discuss Diagnostic Considerations in ET and PV1
CDK4/6 inhibitor therapy1
TROP2-directed antibody-drug conjugates1
NSCLC1
EGFR1
HER2+ Gastroesophageal Adenocarcinoma1
Biliary Tract Cancer1
Generic platforms filtered out.
High Confidence
Est. Listeners
250,001+
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
This ShowCategory Avg
No category insights available.
📡
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
DC
Decera Clinical Education
2 eps
HP
healthcare professional
1 ep
Recent guests
AM
Alessandro M. Vannucchi, MD
2 eps
EH
Erika Hamilton, MD, FASCO
1 ep
IK
Ian Krop, MD, PhD
1 ep
PA
patient advocate
1 ep
EB
early breast cancer survivor
1 ep
NH
Nadia Harbeck, MD
1 ep
FB
Francois-Clement Bidard, MD, PhD
1 ep
AM
Amit Mahipal, MD, MPH
1 ep
SP
Shubham Pant, MD
1 ep
AB
Aditya Bardia, MD, MPH, FASCO
1 ep
RR
Ruta Rao, MD
1 ep
AP
advanced practice professionals
1 ep
CR
Ciro Rinaldi, MD, PhD
1 ep
AM
Anthony M. Hunter, MD
1 ep
DT
Douglas Tremblay, MD
1 ep
CR
Ciro Rinaldi MD, PhD
1 ep
Recent episodes
Thrombotic Events and ET/PV: What You Should Know
Apr 30, 2026
22m 08s
Global Experts Discuss Current and Emerging Treatments for ET and PV
Apr 30, 2026
17m 01s
Global Experts Discuss Diagnostic Considerations in ET and PV
Apr 29, 2026
14m 55s
Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer
Apr 17, 2026
22m 41s
Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes
Apr 15, 2026
41m 42s
🔗
Social Links & Contact
Official channels & resources
🌐
Official Website
Login
📡
RSS Feed
Login
Episodes
13
~2.2 per week
Avg length
27m 46s
14m 55s – 44m 46s
Range
Sep 2020 – Apr 2026
Topics
60
oncology, polycythemia vera +58
Guests
16
Alessandro M. Vannucchi, MD +15 · last 13 eps
13 of 13
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/30/26 |  Thrombotic Events and ET/PV: What You Should Know✨ | thrombotic eventspolycythemia vera+4 | Anthony M. Hunter, MDDouglas Tremblay, MD | Decera Clinical Education | — | thrombotic eventsPV+5 | — | 22m 08s | |
| 4/30/26 |  Global Experts Discuss Current and Emerging Treatments for ET and PV✨ | essential thrombocythemiapolycythemia vera+4 | Ciro Rinaldi MD, PhDAlessandro M. Vannucchi, MD | Decera Clinical Education | — | ETPV+5 | — | 17m 01s | |
| 4/29/26 |  Global Experts Discuss Diagnostic Considerations in ET and PV✨ | diagnosisessential thrombocythemia+3 | Ciro Rinaldi, MD, PhDAlessandro M. Vannucchi, MD | Global Experts Discuss Diagnostic Considerations in ET and PV | — | diagnostic considerationsET+3 | — | 14m 55s | |
| 4/17/26 |  Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer✨ | HER2-positive metastatic breast cancerfirst-line therapy+3 | Erika Hamilton, MD, FASCOIan Krop, MD, PhD | Decera Clinical Education | — | HER2-positivemetastatic breast cancer+3 | — | 22m 41s | |
| 4/15/26 |  Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes✨ | patient carebreast cancer+4 | patient advocateearly breast cancer survivor | Decera Clinical Education | — | breast cancerpatient advocacy+5 | — | 41m 42s | |
| 4/15/26 |  Role of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Experts Share Their Thoughts on Current Practice and Future Opportunities✨ | AKT inhibitorsPI3K inhibitors+5 | Nadia Harbeck, MDFrancois-Clement Bidard, MD, PhD | Decera Clinical Education | — | AKT inhibitorsPI3K inhibitors+5 | — | 31m 22s | |
| 4/14/26 |  Patient-Centered Management of CDK4/6 Inhibitor Therapy: Adverse Event Mitigation, Adherence, and Persistence in HR+/HER2- Breast Cancer✨ | patient-centered strategiesCDK4/6 inhibitor therapy+4 | — | CDK4/6 inhibitor therapyDecera Clinical Education | HR-positive/HER2-negative breast cancer | CDK4/6 inhibitorsbreast cancer+4 | — | 44m 46s | |
| 4/13/26 |  TROP2-Directed Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer: Current Use in Clinical Practice and Future Directions✨ | TROP2-directed therapynon-small-cell lung cancer+3 | — | TROP2-directed antibody-drug conjugatesNSCLC+1 | — | TROP2antibody-drug conjugates+4 | — | 33m 13s | |
| 4/13/26 |  Emerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer✨ | emerging therapiesHER2-positive cancer+3 | Amit Mahipal, MD, MPHShubham Pant, MD | Decera Clinical EducationHER2+ Gastroesophageal Adenocarcinoma+1 | — | HER2-positivegastroesophageal adenocarcinoma+3 | — | 39m 12s | |
| 3/26/26 |  Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC✨ | HER2-negative breast cancermetastatic breast cancer+3 | Aditya Bardia, MD, MPH, FASCORuta Rao, MD | Decera Clinical Education | — | HER2-negativemetastatic breast cancer+3 | — | 19m 16s | |
| 3/25/26 |  Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer✨ | biomarker testingcolorectal cancer+3 | advanced practice professionals | Decera Clinical Education | colorectal cancer | biomarker testingcolorectal cancer+3 | — | 33m 23s | |
| 3/25/26 |  Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer✨ | biomarker testingsolid tumors+3 | — | Decera Clinical Education | Prostate Cancer | biomarker testingprostate cancer+4 | — | 22m 19s | |
| 3/23/26 |  Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026✨ | bladder cancertreatment options+4 | — | ASCOBCG+2 | NMIBC | bladder cancertreatment+6 | — | 18m 57s |
Showing 13 of 13
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
8 placements across 8 markets.
Chart Positions
8 placements across 8 markets.